Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the rt_theme domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/u130574652/domains/nextlabs.co.in/public_html/wp-includes/functions.php on line 6114
NEXOLAN-5MD/10MD/15MD (OLANZAPINE TABLETS) – Next Labs
  1. Home
  2. Our Products
  3. NEXOLAN-5MD/10MD/15MD (OLANZAPINE TABLETS)

NEXOLAN-5MD/10MD/15MD (OLANZAPINE TABLETS)

DESCRIPTION

Olanzapine tablets are an antipsychotic. It may increase the risk of death when used to treat mental problems caused by dementia in elderly patients. Most of the deaths were linked to heart problems or infection. Olanzapine tablets are not approved to treat mental problems caused by dementia. Olanzapine tablets are not approved for use in all children. If olanzapine tablets are prescribed for your child, talk with the doctor to be sure that olanzapine tablets are right for your child.

DOSAGE

Drowsiness, dizziness, lightheadedness, stomach upset, dry mouth, constipation, increased appetite, or weight gain may occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly. To reduce the risk of dizziness and lightheadedness, get up slowly when rising from a sitting or lying position.

CLINICAL PHARMACOLOGY

Olanzapine has a higher affinity for 5-HT2A serotonin receptors than D2 dopamine receptors, which is a common property of all atypical antipsychotics, aside from the benzamide antipsychotics such as amisulpride. Olanzapine also had the highest affinity of any second-generation antipsychotic towards the P-glycoprotein in one in vitro study.

INDICATIONS

Oral ZYPREXA is indicated for the treatment of schizophrenia. Efficacy was established in three clinical trials in adult patients with schizophrenia: two 6-week trials and one maintenance trial. In adolescent patients with schizophrenia (ages 13-17), efficacy was established in one 6-week trial

CONTRA INDICATIONS

None with ZYPREXA (olanzapine) monotherapy. When using ZYPREXA (olanzapine) and fluoxetine in combination, also refer to the Contraindications section of the package insert for Symbyax. For specific information about the contraindications of lithium or valproate, refer to the Contraindications section of the package inserts for these other products.

SIDE EFFECTS

Bloating or swelling of the face, arms, hands, lower legs, or feet, blurred vision, change in vision, change in walking and balance, clumsiness or unsteadiness, difficulty with speaking, difficulty with swallowing, drooling, impaired vision, inability to sit still, loss of balance control, mask-like face, muscle trembling, jerking, or stiffness, need to keep moving, rapid weight gain

DRUG INTERACTIONS

Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor’s approval.

AVAILABILITY

NEXOLAN-5MD/10MD/15MD is available in strips  of  ten  capsules containing OLANZAPINE TABLETS.

About us

NEXT LABS, a name that that signifies the state of well-being is dedicated to promoting healthcare for more than a decade and provides high quality products for customers focused on healthcare and diseases. Since its inception, NEXT has been on a quest to sustain and improve the quality of life with the ultimate purpose of making the world a healthier place.